Cargando…
EVITA: a tool for the early EValuation of pharmaceutical Innovations with regard to Therapeutic Advantage
BACKGROUND: New drugs are generally claimed to represent a therapeutic innovation. However, scientific evidence of a substantial clinical advantage is often lacking. This may be the result of using inadequate control groups or surrogate outcomes only in the clinical trials. In view of this, EVITA wa...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858124/ https://www.ncbi.nlm.nih.gov/pubmed/20233429 http://dx.doi.org/10.1186/1472-6904-10-5 |